Gabriele Cerrone raises ownership to 34.93% of TLSA after buying shares at $0.99, increasing holdings to 44.81M.
Tiziana Life Sciences (TLSA) executive chairman Gabriele Cerrone purchased 42,357 common shares at $0.99 per share through Panetta Partners Ltd. The transaction lifts his total holdings to 44.81 million shares.
Prior to the purchase, Cerrone’s stake in TLSA was below 34.93%. The move follows no recent insider activity disclosed by the company in public filings.
The acquisition reflects confidence from the company’s founder and largest shareholder amid ongoing development of TLSA’s pipeline in autoimmune and neurodegenerative diseases.